{"id":31589,"date":"2017-06-05T17:54:03","date_gmt":"2017-06-05T15:54:03","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=31589"},"modified":"2017-06-05T18:10:50","modified_gmt":"2017-06-05T16:10:50","slug":"filctem-riunione-nazionale-occupazione-sviluppo-diritti-nel-settore-farmaceutico","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/filctem-riunione-nazionale-occupazione-sviluppo-diritti-nel-settore-farmaceutico\/","title":{"rendered":"Filctem. National meeting on employment, development, rights in the pharmaceutical sector"},"content":{"rendered":"

Rome, June 5th 2017<\/p>\n

To the regional and territorial general secretaries<\/p>\n

To the members of the regional and territorial secretariat with responsibility for pharmaceuticals<\/p>\n

\"RisultatiGiven the succession of scandals involving the NHS and the pharmaceutical sector;<\/p>\n

Given the position of the national secretariat with respect to thescientific information activity of the drug<\/strong> and the continuing propensity of companies to contractually outsource activities;<\/p>\n

Given the increasingly scarce investments of companies in research in our country;<\/p>\n

Given the potential of the sector to support the country's candidacy for the headquarters of the EMA;<\/p>\n

Having said all this, the national meeting of the subjects in the address has been convened to discuss the next initiatives to be put in place in order to safeguard employment, development, rights proportional to the earnings that companies are forfeiting year after year.<\/p>\n

The meeting will be held in the meeting room of theNational Enel Ark<\/strong>, in Rome in Via di Villa Patrizi n. 2\/b the day June 14 at 10.30<\/strong>.<\/p>\n

The general secretary Emilio Miceli will be present at the meeting.<\/p>\n

Given the importance of the topic, attendance and punctuality are recommended.<\/p>\n

Brotherly greetings.<\/p>\n

The National Pharmaceutical Chemical Department<\/p>\n

\"\"<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Roma, 5 giugno 2017 Ai segretari generali regionali e territoriali Ai membri di segreteria regionali e territoriali con delega al farmaceutico Visto il susseguirsi di scandali che interessano il servizio sanitario nazionale e il settore farmaceutico; Vista la posizione della segreteria nazionale rispetto all’attivit\u00e0 di informazione scientifica del farmaco e la propensione continua delle aziende …<\/p>","protected":false},"author":4,"featured_media":31371,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[21,44],"class_list":["post-31589","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-informatori-scientifici","tag-sindacati"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/31589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=31589"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/31589\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/31371"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=31589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=31589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=31589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}